Blakely Lab - Publications

  1. Cell surface trafficking of the antidepressant-sensitive norepinephrine transporter revealed with an ectodomain antibody. Savchenko V, Sung U, Blakely RD (2003) Mol Cell Neurosci 24(4): 1131-50
    › Primary publication · 14697674 (PubMed)
  2. Calcium-dependent inhibition of synaptosomal serotonin transport by the alpha 2-adrenoceptor agonist 5-bromo-N-[4,5-dihydro-1H-imidazol-2-yl]-6-quinoxalinamine (UK14304). Ansah TA, Ramamoorthy S, Montañez S, Daws LC, Blakely RD (2003) J Pharmacol Exp Ther 305(3): 956-65
    › Primary publication · 12626658 (PubMed)
  3. Binding and transport in norepinephrine transporters. Real-time, spatially resolved analysis in single cells using a fluorescent substrate. Schwartz JW, Blakely RD, DeFelice LJ (2003) J Biol Chem 278(11): 9768-77
    › Primary publication · 12499385 (PubMed)
  4. A regulated interaction of syntaxin 1A with the antidepressant-sensitive norepinephrine transporter establishes catecholamine clearance capacity. Sung U, Apparsundaram S, Galli A, Kahlig KM, Savchenko V, Schroeter S, Quick MW, Blakely RD (2003) J Neurosci 23(5): 1697-709
    › Primary publication · 12629174 (PubMed) · PMC6741950 (PubMed Central)
  5. A mutation in the human norepinephrine transporter gene (SLC6A2) associated with orthostatic intolerance disrupts surface expression of mutant and wild-type transporters. Hahn MK, Robertson D, Blakely RD (2003) J Neurosci 23(11): 4470-8
    › Primary publication · 12805287 (PubMed) · PMC6740799 (PubMed Central)
  6. Altered striatal function and muscarinic cholinergic receptors in acetylcholinesterase knockout mice. Volpicelli-Daley LA, Hrabovska A, Duysen EG, Ferguson SM, Blakely RD, Lockridge O, Levey AI (2003) Mol Pharmacol 64(6): 1309-16
    › Primary publication · 14645660 (PubMed)
  7. Targeting cell surface receptors with ligand-conjugated nanocrystals. Rosenthal SJ, Tomlinson I, Adkins EM, Schroeter S, Adams S, Swafford L, McBride J, Wang Y, DeFelice LJ, Blakely RD (2002) J Am Chem Soc 124(17): 4586-94
    › Primary publication · 11971705 (PubMed)
  8. Neurotoxin-induced degeneration of dopamine neurons in Caenorhabditis elegans. Nass R, Hall DH, Miller DM, Blakely RD (2002) Proc Natl Acad Sci U S A 99(5): 3264-9
    › Primary publication · 11867711 (PubMed) · PMC122507 (PubMed Central)
  9. Monoamine transporter gene structure and polymorphisms in relation to psychiatric and other complex disorders. Hahn MK, Blakely RD (2002) Pharmacogenomics J 2(4): 217-35
    › Primary publication · 12196911 (PubMed)
  10. Genetic basis of clinical catecholamine disorders. Garland EM, Hahn MK, Ketch TP, Keller NR, Kim CH, Kim KS, Biaggioni I, Shannon JR, Blakely RD, Robertson D (2002) Ann N Y Acad Sci : 506-14
    › Primary publication · 12438171 (PubMed)